NCT03548740 is a clinical trial of Human Papillomavirus in Papillomavirus Infections, sponsored by Peking Union Medical College Hospital.

Who is sponsoring NCT03548740?

NCT03548740 is sponsored by Peking Union Medical College Hospital.

What drugs are being tested in NCT03548740?

Interventions in NCT03548740: Human Papillomavirus.

What condition does NCT03548740 study?

NCT03548740 studies Papillomavirus Infections.

Is NCT03548740 still recruiting?

NCT03548740 is currently status unknown. Last updated 6 February 2019.

Last reviewed 2019-02-06 · How we verify

NCT03548740

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diversity Analysis of Vaginal Microbiota on Women With High-risk Human Papillomavirus Infection

Status unknown Last updated 6 February 2019

What this trial tests

trial testing Human Papillomavirus in Papillomavirus Infections in 151 participants. Status unknown.

Timeline

1 September 2018

Primary endpoint
20 January 2020

20 May 2020

Quick facts

Lead sponsor	Peking Union Medical College Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	151
Start date	1 September 2018
Primary completion	20 January 2020
Estimated completion	20 May 2020
Sites	1 location across China

Drugs / interventions tested

Human Papillomavirus — full drug profile →

Conditions studied

Papillomavirus Infections — all drugs for Papillomavirus Infections →

Sponsor

Peking Union Medical College Hospital

Who can join

Adults 25 to 50, female only, with Papillomavirus Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Since other genital infections enhance HIV susceptibility by inducing inflammation, the investigators study the relationship between the vaginal microbiota composition and the risk of HPV infection, cervical cytological abnormalities.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Research of the potential biomarkers in vaginal microbiome for persistent high-risk human papillomavirus infection.
Chao X, Sun T, Wang S, Tan X, et al · · 2020 · cited 29× · PMID 32175393 · DOI 10.21037/atm.2019.12.115
Research of the Potential Vaginal Microbiome Biomarkers for High-Grade Squamous Intraepithelial Lesion.
Chao X, Wang L, Wang S, Lang J, et al · · 2021 · cited 13× · PMID 34621755 · DOI 10.3389/fmed.2021.565001

Verify or expand the search:

Other recruiting trials for Papillomavirus Infections

Currently open trials in the same condition.

NCT05797246 — Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP) · Phase 2 · active not recruiting
NCT05450705 — V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071) · Phase 3 · active not recruiting
NCT05285826 — Efficacy, Immunogenicity, and Safety of V503 in Chinese Males (V503-052) · Phase 3 · active not recruiting
NCT04724980 — Adjuvant PRGN-2012 in Adult Patients With Recurrent Respiratory Papillomatosis · Phase 1, PHASE2 · active not recruiting
NCT04708041 — Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069) · Phase 3 · active not recruiting

Other Peking Union Medical College Hospital trials

Trials by the same sponsor.

NCT07466251 — PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke · Phase 4 · not yet recruiting
NCT06743321 — Speech-to-speech Voice-cloning Care (SVCC) to Improve ICU-acquired Anxiety for Critically Ill Patients · NA · not yet recruiting
NCT07590336 — 68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma · Phase 1, PHASE2 · not yet recruiting
NCT07515976 — Mapping of Genomic Structural Variations in Major Birth Defects · not yet recruiting
NCT07386756 — Early Precise Identification and Intervention Strategies for Individuals at High Risk of Prediabetes · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03548740 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Peking Union Medical College Hospital
Last refreshed: 6 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03548740.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing